Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05026333 · ClinicalTrials.gov registry record · NA

Cognitive and Biological Responses in Stress

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT05026333 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05026333, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The goal of this pilot part of the study (Step 1) is to identify the optimal population of high and low anxiety and stress individuals who will differentially respond to a laboratory stress task as measured by changes in subjective stress response (affect), cognition, attention, and biological measures (autonomic and metabolite responses). Based on experience with different study populations, the investigator's believe that a healthy, homogenous population (Caucasian, women, premenopausal) with higher levels of state anxiety and perceived stress, and with greater responsiveness to laboratory stress tasks (which can also be used in the probiotic intervention study in Step 2) will provide the highest likelihood of identifying the underlying central mechanisms of stress responsiveness in Step 1 and then for the probiotic intervention in Step 2. For this pilot study, the investigator's will look at baseline measures to determine differences in responses to four subjective (affect/cognition/attention) stress tasks (primary endpoints) and biological (secondary endpoints) measures in a high stress group and a low stress group. If for Step 1 of the study, the investigator's are able to verify the stratification of the participants into high and low stress groups based on questionnaire data and show differences between participants with high and low perceived stress in psychological characteristics, lab stress tasks and potentially in biological responses, this will help to determine the optimal cut off values, and the optimal stress tasks to be conducted in the planned probiotic intervention study of Step 2.

Interventions

  • OTHER Cognitive Stress Testing

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-06-25
Est. Completion 2022-07-15
Phase NA

What the Registry Record Tells You About NCT05026333

The ClinicalTrials.gov registry entry for NCT05026333 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cognitive Stress Testing is the first listed.

NCT05026333 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05026333 about?

NCT05026333 is a clinical study titled "Cognitive and Biological Responses in Stress". The goal of this pilot part of the study (Step 1) is to identify the optimal population of high and low anxiety and stress individuals who will differentially respond to a laboratory stress task as measured by changes in subjective stress response (affect), cognition, attention, and biological measu...

What is the current status of trial NCT05026333?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-06-25. Estimated completion is 2022-07-15.

What interventions are being tested in trial NCT05026333?

The interventions under investigation include: Cognitive Stress Testing (OTHER).

Who is sponsoring clinical trial NCT05026333?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.